Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 458 followers
Latest posts
Last updated 4 days ago
ViiV Healthcare premieres early data showing antiviral activity against integrase resistance from its investigational, third-generation integrase inhibitor
4 days ago
Data, along with results from a phase I study, are the first...
ViiV Healthcare announces positive new data for Apretude use during pregnancy at AIDS 2024
4 days ago
Open label extension show maternal and pregnancy outcomes with Apretude exposure were...
ViiV Healthcare announces positive data demonstrating 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy for maintenance therapy of HIV-1
4 days ago
Largest head-to-head randomised clinical trial between DTG/3TC and BIC/FTC/TAF showed DTG/3TC demonstrated...
Blenrep (belantamab mafodotin) combinations in multiple myeloma application accepted for review by the European Medicines Agency
8 days ago
Regulatory submission supported by phase III head-to-head DREAMM-7 and DREAMM-8 trials
ViiV Healthcare to announce data from largest head-to-head randomised clinical trial for 2-drug regimen Dovato against 3-drug regimen Biktarvy at AIDS 2024
12 days ago
The presentation is one of 25 abstracts evaluating the company’s portfolio of...
Brazil and Thailand become first malaria-endemic countries to launch new single-dose radical cure medicine to prevent the relapse of Plasmodium vivax malaria
22 days ago
Launch of single-dose tafenoquine, co-administered with chloroquine, is another step closer to...
GSK and CureVac to restructure collaboration into new licensing agreement
23 days ago
GSK acquires full rights to develop, manufacture and commercialise globally mRNA candidate...
Statement: Zantac (ranitidine) litigation – Gross case
29 days ago
GSK has reached a confidential settlement with Martin Gross resolving the case...
Statement: US Centers for Disease Control and Prevention’s Advisory Committee on Immunisation Practices updates recommendations on adult RSV vaccines ahead of the next season
about 1 month ago
GSK today announced that the US CDC ACIP voted in favour of...
Jemperli (dostarlimab) plus chemotherapy application accepted for review by the European Medicines Agency to expand use to all patients with primary advanced or recurrent endometrial cancer
about 1 month ago
Regulatory submission supported by statistically significant and clinically meaningful progression-free and overall...
GSK’s Omjjara (momelotinib) approved in Japan for treatment of myelofibrosis
about 1 month ago
Omjjara approved for use in both newly diagnosed or previously treated myelofibrosis...
Statement: Zantac (ranitidine) litigation – Kasza case
about 2 months ago
GSK welcomes the plaintiff's voluntary dismissal of Zantac case (Kasza) in Illinois.